Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Helios CELMoD by Bristol-Myers Squibb for Solid Tumor: Likelihood of Approval
Helios CELMoD is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor. According to GlobalData,...